BCDA BioCardia Inc

Price (delayed)

$0.9189

Market cap

$10.45M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.91

Enterprise value

$9.91M

?
Relative Growth: Rel. Growth: 16
Relative Strength: Rel. Strength: 5
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 4

BioCardia, Inc., headquartered in San Carlos, California, is developing regenerative biologic therapies to treat cardiovascular and respiratory disease. CardiAMP autologous and Neurokinin-1 Receptor Positive allogenic cell therapies are the Company's ...

Highlights
The EPS has soared by 61% YoY and by 26% from the previous quarter
The debt has dropped by 52% year-on-year and by 22% since the previous quarter
BCDA's quick ratio has plunged by 66% from the previous quarter but it is up by 21% YoY
BioCardia's gross profit has plunged by 100% YoY
BioCardia's revenue has plunged by 100% YoY

Key stats

What are the main financial stats of BCDA

BCDA stock price

How has the BioCardia stock price performed over time
Intraday
5.07%
1 week
0.23%
1 month
-18.68%
1 year
-57.65%
YTD
-26.49%
QTD
-24.06%

Financial performance

How have BioCardia's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$7.82M
Net income
-$7.78M
Gross margin
N/A
Net margin
N/A
BioCardia's gross profit has plunged by 100% YoY
BioCardia's revenue has plunged by 100% YoY
BioCardia's operating income has increased by 8% YoY and by 6% from the previous quarter
BioCardia's net income has increased by 7% YoY and by 6% from the previous quarter

Price vs fundamentals

How does BCDA's price correlate with its fundamentals

Growth

What is BioCardia's growth rate over time

Valuation

What is BioCardia stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 61% YoY and by 26% from the previous quarter
The equity is up by 30% year-on-year
BioCardia's revenue has plunged by 100% YoY

Efficiency

How efficient is BioCardia business performance
The company's return on equity has surged by 82% YoY and by 81% QoQ
The ROA has contracted by 4.3% YoY but it has grown by 2.3% from the previous quarter

Dividends

What is BCDA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BCDA.

Financial health

How did BioCardia financials performed over time
BCDA's total assets is 38% lower than its total liabilities
BCDA's quick ratio has plunged by 66% from the previous quarter but it is up by 21% YoY
BCDA's current ratio has shrunk by 63% QoQ but it is up by 14% YoY
The debt is 139% greater than the equity
BioCardia's debt to equity has plunged by 166% from the previous quarter but it has increased by 30% YoY
The debt has dropped by 52% year-on-year and by 22% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.